Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Scipion Capital hires two ahead of new investment and product launches

Thursday, November 03, 2011
Opalesque Industry Update - Scipion Capital (“Scipion”), the African investment specialist, has expanded its team in Geneva and London in anticipation of new investment and product launches over the next six months.

Two new hires, Jonathan Hargreaves as Analyst and Jean Cochard as Office Manager, are the latest additions to the firm’s London and Geneva offices respectively. These follow the recent appointment of Chris Jenkins to a revamped COO position, where he will be leading the marketing drive for the firm’s highly successful Commodities Trade Finance Fund (“CTF”) fund. The fund, which finances softs and minerals commodity-trading, recently celebrated its 4th anniversary and has generated positive returns in every month since inception.

In addition to the office expansion heralding a significant drive for new investment, Scipion are also preparing to launch a major new product. In anticipation of these developments, the new members of the team will be providing added support and expertise during an increasingly busy period for the company.

Jonathan Hargreaves has been hired as an Analyst by Scipion to provide research and logistical support to the management team which oversees the firm’s range of equity and trade finance investment strategies. He will principally assist from a risk mitigation perspective on the firm’s flagship CTF fund, as well as researching new African investment themes for the fund to pursue.

A former political and security risk analyst, Jonathan has travelled and worked in a number of Eastern and Southern African countries. Having originally built up financial services experience while working for an offshore trust company, he joins Scipion from IHS Jane’s, where he worked as a Defence Industry Reporter and Analyst.

Jean Cochard has joined Scipion to manage the day to day running of the Geneva office. Jean first built up his financial background while working for Renault Finance SA as a junior dealer. More recently, he was chief supervisor of the back-office and assisted the head accountant at Cosmorex SA Geneva, an international forex and precious metals broker.

Nicolas Clavel, CIO and Founder of Scipion, commented:

“The next six months are set to be something of a watershed for Scipion. With new products in the pipeline and an increased focus on driving investment into our funds, we are expecting to see a dramatic increase in activity and investor interest. With this in mind, we have moved to strengthen our team across both our offices. Jonathan and Jean represent the kind of hires that will not only help us manage this anticipated growth organically, but also play key roles in the long term future of the firm.”

(press release)


Scipion Capital is a uniquely focused team of finance professionals whose senior management have significant experience of banking and investing in emerging markets, particularly in Africa. Scipion African Opportunities Fund SPC (domiciled in the Cayman Islands and registered with the Cayman Islands Monetary Authority) is an Exempted Segregated Portfolio Company incorporated with limited liability with a number of different share classes all focused on Africa. Scipion clients include hedge funds, European family offices, financial advisors, private banks, endowments and pension funds.

See our most recent article on Scipion:
27.08.2010 Opalesque Exclusive: All three Scipion funds grow stronger on weak U.S. dollar and strengthening African currencies Source

BG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
What is the size of this fund? Is it registered?   November 04, 2011 09:51:53 AM
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its